SERIOUS INFECTION WITH TOCILIZUMAB COMPARED TO TNF-INHIBITORS AND OTHER BDMARDS IN RHEUMATOID ARTHRITIS PATIENTS: DOES LINE OF THERAPY MATTER?

被引：0
|
作者：
Lauper, K. [1 ,2 ,3 ]
Kearsley-Fleet, L. [3 ]
Davies, R. [3 ]
Watson, K. [3 ]
Lunt, M. [3 ]
Hyrich, K. [3 ,4 ]
机构：
[1] Hop Univ Geneve HUG, Rheumatol, Geneva, Switzerland
[2] Univ Geneva, Fac Med, Internal Med, Geneva, Switzerland
[3] Univ Manchester, Ctr Musculoskeletal Res, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England
[4] Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Musculoskeletal Biomed Res Ctr, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0241
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] SERIOUS INFECTION WITH TOCILIZUMAB COMPARED TO TNF-INHIBITORS AND OTHER BDMARDS IN RHEUMATOID ARTHRITIS PATIENTS: DOES LINE OF THERAPY MATTER?
    Lauper, Kim
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    Watson, Kath
    Lunt, Mark
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2021, 60
  • [2] O32 Serious infection with tocilizumab compared to TNF-inhibitors and other bDMARDS in rheumatoid arthritis patients: does line of therapy matter?
    Lauper, Kim
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    Watson, Kath
    Lunt, Mark
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2021, 60
  • [3] Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
    Huoponen, Saara
    Aaltonen, Kalle J.
    Viikinkoski, Jaana
    Rutanen, Jarno
    Relas, Heikki
    Taimen, Kirsi
    Puolakka, Kari
    Nordstrom, Dan
    Blom, Marja
    [J]. PLOS ONE, 2019, 14 (07):
  • [4] The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea
    Jeon, Ha-Lim
    Kim, Seoyoung C.
    Park, So-Hee
    Shin, Ju-Young
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 362 - 363
  • [5] The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea
    Jeon, Ha-Lim
    Kim, Seoyoung C.
    Park, So-Hee
    Shin, Ju-Young
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (05) : 989 - 995
  • [6] Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)
    Backhaus, M.
    Kaufmann, J.
    Richter, C.
    Vollmer, M.
    Volberg, C.
    Wassenberg, S.
    Roske, A.
    Hellmann, P.
    Gaubitz, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 119 - 120
  • [7] B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V.
    Martins, N.
    Canhao, H.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 905 - 905
  • [8] B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V.
    Martins, N.
    Canhao, H.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A5 - A5
  • [9] SERUM ADIPOKINES PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF-INHIBITORS
    Novella-Navarro, M.
    Hernandez-Breijo, B.
    Genre, F.
    Lera-Gomez, L.
    Pulito-Cueto, V.
    Nuno, L.
    Villalba, A.
    Balsa, A.
    Plasencia, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 972 - 972
  • [10] Screening for Urinary Tract Infection in Rheumatoid Arthritis Patients Treated with TNF-Inhibitors in the Daily Clinic
    Hansen, Renata Baronaite
    Hesselvig, Anne Brun
    Arpi, Rolf Magnus
    Jonassen, Eva Kristin
    Bukh, Gunhild
    Madsen, Ole Rintek
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345